Idarubicin Hydrochloride
- Product NDC
- 0703-4155
- 11-digit product format
- 007034155
- Labeler code
- 0703
- Product ID
- 0703-4155_902aa4cb-c005-480e-8275-10145b8afefe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Idarubicin Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA065036
- Marketing category
- ANDA
- Marketing start
- 2002-10-01
- Marketing end
- 0000-00-00
- Substance
- IDARUBICIN HYDROCHLORIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-4155-11 | 00703415511 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4155-11) > 10 mL in 1 VIAL, SINGLE-DOSE | 2002-10-01 | 0000-00-00 | No | No | Current |